Jan Makela - 03 Jan 2023 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role
CEO, Imaging
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Issuer symbol
GEHC
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 19:47:29 UTC
Next filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GEHC Common stock, par value $0.01 per share Award +32 32 03 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GEHC Employee Stock Option (right to buy) Award +1,469 1,469 04 Jan 2023 Common stock, par value $0.01 per share 1,469 $129.52 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +206 206 04 Jan 2023 Common stock, par value $0.01 per share 206 $142.15 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +2,328 2,328 04 Jan 2023 Common stock, par value $0.01 per share 2,328 $142.15 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +4,408 4,408 04 Jan 2023 Common stock, par value $0.01 per share 4,408 $135.92 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +7,345 7,345 04 Jan 2023 Common stock, par value $0.01 per share 7,345 $161.30 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +54,701 54,701 04 Jan 2023 Common stock, par value $0.01 per share 54,701 $40.40 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +5,967 5,967 04 Jan 2023 Common stock, par value $0.01 per share 5,967 $57.74 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +4,037 4,037 04 Jan 2023 Common stock, par value $0.01 per share 4,037 $51.67 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +240 240 04 Jan 2023 Common stock, par value $0.01 per share 240 $63.51 Direct F1, F3
transaction GEHC Employee Stock Option (right to buy) Award +28,615 28,615 04 Jan 2023 Common stock, par value $0.01 per share 28,615 $63.51 Direct F1, F3
transaction GEHC Employee Stock Option (right to buy) Award +66,191 66,191 04 Jan 2023 Common stock, par value $0.01 per share 66,191 $76.37 Direct F1, F4
transaction GEHC Restricted Stock Units Award +3,243 3,243 04 Jan 2023 Common stock, par value $0.01 per share 3,243 Direct F1, F5, F6
transaction GEHC Restricted Stock Units Award +19,555 19,555 04 Jan 2023 Common stock, par value $0.01 per share 19,555 Direct F1, F5, F7
transaction GEHC Restricted Stock Units Award +14,846 14,846 04 Jan 2023 Common stock, par value $0.01 per share 14,846 Direct F1, F5, F8
transaction GEHC Restricted Stock Units Award +8,209 8,209 04 Jan 2023 Common stock, par value $0.01 per share 8,209 Direct F1, F5, F9
transaction GEHC Restricted Stock Units Award +14,569 14,569 04 Jan 2023 Common stock, par value $0.01 per share 14,569 Direct F1, F5, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.
F2 Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.
F3 Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023.
F4 Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will become exercisable on July 1, 2023 and 50% will become exercisable on July 1, 2024.
F5 Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F6 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.
F7 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024.
F8 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.
F9 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on July 1, 2023 and 50% will vest on July 1, 2024.
F10 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.